Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jan-Erik Palmgren"'
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 14, Iss 5, Pp 446-451 (2022)
Externí odkaz:
https://doaj.org/article/6ddf5fcaadfa46a3996b73ebcb977493
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 6, Pp 687-693 (2021)
Externí odkaz:
https://doaj.org/article/8dc4d6d3e1d24e7c9f899f0c06a4b411
Autor:
Kristiina Vuolukka, Päivi Auvinen, Erno Tiainen, Jan-Erik Palmgren, Janne Heikkilä, Jan Seppälä, Sirpa Aaltomaa, Vesa Kataja
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2020)
Abstract Background The use of stereotactic body radiotherapy (SBRT) as the primary treatment modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was to analyze the long-term results of PCa patients treated with S
Externí odkaz:
https://doaj.org/article/b213e4fab5404fdfaaca9282608fb499
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background As aging is the most significant risk factor for cancer development, long-term prostate cancer (PCa) survivors have an evident risk of developing subsequent primary cancers (SPCs). Radiotherapy itself is an additional risk factor
Externí odkaz:
https://doaj.org/article/18429d5291ce43188f143f222b837909
Autor:
Sirpa Aaltomaa, K. Vuolukka, Vesa Kataja, Erno Tiainen, Jan-Erik Palmgren, Jan Seppälä, Päivi Auvinen, Janne Heikkilä
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2020)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background The use of stereotactic body radiotherapy (SBRT) as the primary treatment modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was to analyze the long-term results of PCa patients treated with SBRT. Meth
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)
BMC Cancer
BMC Cancer
Background As aging is the most significant risk factor for cancer development, long-term prostate cancer (PCa) survivors have an evident risk of developing subsequent primary cancers (SPCs). Radiotherapy itself is an additional risk factor for cance
Autor:
Tuuli Voutilainen, K. Vuolukka, Vesa Kataja, Sirpa Aaltomaa, Päivi Auvinen, Jan-Erik Palmgren
Publikováno v:
Brachytherapy. 18:583-588
Purpose The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). Methods and Materials
Autor:
Melissa Christiaens, Marisol De Brabandere, Taran Paulsen Hellebust, Janaki Hadjiev, Alina Sturdza, Ina M. Jürgenliemk-Schulz, Israel Fortin, Søren M. Bentzen, Kari Tanderup, Umesh Mahantshetty, Stefan Ecker, Deidre Batchelar, Stéphanie Smet, Kathrin Kirchheiner, Fleur Huang, Kenji Yoshida, Katarina Majercakova, Yusung Kim, Petra Georg, Anne Beate Langeland Marthinsen, Johannes Dimopoulos, Neamat Hegazy, Petra Trnkova, Arun S Oinam, Bernard Oosterveld, Primoz Petric, Beth Erickson, Gerry Lowe, Itxa Mora, Mario Federico, Jan-Erik Palmgren, Ludy C.H.W. Lutgens, Marianne S. Assenholt, Margit Valgma, Elzbieta van der Steen-Banasik, Karen S. Nkiwane, Kjersti Bruheim, Henrike Westerveld, Elena Fidarova, Bradley R. Pieters, Christian Kirisits, Richard Pötter, Lars Fokdal, Ian Dilworth, Susovan Banerjee, Marit Sundset, Robert Hudej, Geraldine Jacobson, Erik Van Limbergen, Maarit Anttila, Thomas Liederer, Isabelle Dumas, Elke Dörr, Pittaya Dankulchai, L.T. Tan, Jusheng An, Barbara Segedin, Jason Rownd, Christine Haie-Meder, Diane Whitney, Francois Bachand, Noha Jastaniyah, Martijn Ketelaars, Rachel Cooper, Peter Hoskin, Monica Serban, E. Villafranca, Nicole Nesvacil, Astrid de Leeuw, Hilde Janssen, Jacob Christian Lindegaard, Dina Najjari Jamal, Kees Koedooder, Cyrus Chargari, Maximilian Schmid, Gergely Antal, Thomas Berger, Robin Ristl, Remi A. Nout, Nina Boje Kibsgaard Jensen, Brigitte Reinniers, Tamara Diendorfer, Geetha Menon, Sofia Spampinato, Dragan Misimovic, Joyce Siu Yu Wong, Laura Motisi, Anders Schwartz-Vittrup, Bhavana Rai, Joanna Gora, Jamema Swamidas, Peter Bownes
Publikováno v:
Pötter, R, Tanderup, K, Schmid, M P, Jürgenliemk-Schulz, I, Haie-Meder, C, Fokdal, L U, Sturdza, A E, Hoskin, P, Mahantshetty, U, Segedin, B, Bruheim, K, Huang, F, Rai, B, Cooper, R, van der Steen-Banasik, E, Van Limbergen, E, Pieters, B R, Tan, L T, Nout, R A, De Leeuw, A A C, Ristl, R, Petric, P, Nesvacil, N, Kirchheiner, K, Kirisits, C, Lindegaard, J C & EMBRACE Collaborative Group 2021, ' MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I) : a multicentre prospective cohort study ', The Lancet Oncology, vol. 22, no. 4, pp. 538-547 . https://doi.org/10.1016/S1470-2045(20)30753-1
The Lancet Oncology, 22(4), 538-547. Lancet Publishing Group
lancet oncology, 22(4), 538-547. Lancet Publishing Group
The Lancet Oncology, 22(4), 538-547. Lancet Publishing Group
lancet oncology, 22(4), 538-547. Lancet Publishing Group
Background: The concept of the use of MRI for image-guided adaptive brachytherapy (IGABT) in locally advanced cervical cancer was introduced 20 years ago. Here, we report on EMBRACE-I, which aimed to evaluate local tumour control and morbidity after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c5b5ad754a052b2afe05b1e7536075
https://doi.org/10.5167/uzh-215991
https://doi.org/10.5167/uzh-215991
Autor:
Maarit Anttila, Jan-Erik Palmgren, Siiri-Liisi Kraav, Henna Kärkkäinen, Tommi Tolmunen, Ester Jääskeläinen
Publikováno v:
Brachytherapy. 20(4)
Background and purpose Image guided adaptive brachytherapy, the standard treatment for locally advanced cervical cancer (LACC), is a complex medical procedure that requires an experienced multidisciplinary team. The aims of this analysis were to asse
Autor:
Vuolukka, Kristiina, Auvinen, Päivi, Tiainen, Erno, Jan-Erik Palmgren, Heikkilä, Janne, Seppälä, Jan, Aaltomaa, Sirpa, Kataja, Vesa
Additional file 1. Dose–volume constraints for treatment planning.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3863ce2a6de877dfe98ded139036f87c